Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Isao Goto"'
Autor:
Kazuhiko Fujita, Isao Goto, Tasaburo Takasu, Eriko Tabata, Toshiaki Hanafusa, Yasuhito Fujisaka, Soichiro Ikeda, Naoki Chikuie
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 82:455-460
We report a case of acute respiratory distress syndrome caused by uropathogenic Escherichia coli induced sepsis and treated successfully. A 56-year-old women admitted for high-fever, dyspnea, and disturbance of consciousness on September 11, 2006, wa
Autor:
Takashi Seto, Nobuyuki Katakami, Hiroshi Semba, Taroh Satoh, Minoru Takada, Tetsu Shinkai, Kazuhiko Nakagawa, Masahiko Ando, Toshiyuki Sawa, Shinzoh Kudoh, Naruo Yoshimura, Kaoru Matsui, Shunichi Negoro, Isao Goto, Koji Takeda, Masahiro Fukuoka
Publikováno v:
Journal of Clinical Oncology. 24:3657-3663
Purpose Docetaxel has shown activity in elderly patients with advanced non–small-cell lung cancer (NSCLC). This randomized phase III trial evaluated the efficacy and safety of docetaxel versus vinorelbine (the current standard treatment) in elderly
Autor:
Kazuhiko Nakagawa, Nobuyuki Yamamoto, Naotoshi Sugimoto, Asuka Tsuya, Isao Goto, Shinya Ueda, Koji Matsumoto, Akihiro Tamiya, Takayasu Kurata, Masahiro Fukuoka, Isamu Okamoto, Daisuke Sakai
Publikováno v:
Investigational new drugs. 31(6)
Background Carcinomas of unknown primary site (CUPs) are heterogeneous tumors associated with a poor prognosis. This phase II trial was designed to evaluate the efficacy and safety of a novel combination chemotherapy of S-1 and cisplatin (CDDP) in pa
Autor:
Toshiyuki Sawa, Noriyuki Ebi, Kazuhiko Nakagawa, Isao Goto, Nobuhiko Seki, Masashi Kobayashi, Koji Takeda, Hiroshi Saito, Yasuo Iwamoto, Satoshi Oizumi, Hideo Saka, Kaoru Matsui, Kazuhiko Shibata, Fumio Imamura
Publikováno v:
Journal of Thoracic Oncology. (7):1075-1080
Introduction Combination chemotherapy of irinotecan, a topoisomerase I inhibitor, and cisplatin is a standard treatment in patients with extensive-stage small cell lung cancer (SCLC). Amrubicin, a novel 9-aminoanthracycline, inhibits topoisomerase II